nach oben

International Journal of Clinical Oncology

Erschienen in:

01.02.2011 | Original Article

Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection

verfasst von: Kojun Okamoto, Isamu Koyama, Mitsuo Miyazawa, Yasuko Toshimitsu, Masayasu Aikawa, Katsuya Okada, Etsuko Imabayashi, Hiroshi Matsuda

Erschienen in: International Journal of Clinical Oncology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

An important step in deciding the treatment strategy for pancreatic cancer is to preoperatively predict the possibility of early recurrence. We reviewed whether 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) before pancreatic cancer resection could predict tumor recurrence in the early postoperative period.

Methods

FDG-PET/CT was performed preoperatively on 56 patients with pancreatic cancer. The maximum standardized uptake (SUV_max) values obtained by FDG-PET/CT were compared between two groups: patients with and without recurrence within the first 6 postoperative months. SUV_max analyses were also performed to determine whether age, sex, CA 19-9 values, the operative method, and portal vein resection were also predictive of recurrence within less than 6 months after tumor resection.

Results

The median SUV_max values of the recurrence group and no-recurrence group were 7.9 and 4.2, respectively (P = 0.0042). The SUV_max was the only risk factor for recurrence in the first 6 postoperative months identified by multivariate analysis (P = 0.0062).

Conclusions

Preoperative SUV_max was higher in the recurrence group during the early postoperative period, and a high SUV_max was a risk factor for early postoperative recurrence. Based on these results, we conclude that FDG-PET/CT is predictive of the recurrence of pancreatic cancer in the early postoperative period.

Satoi S, Yanagimoto H, Toyokawa H et al (2009) Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer. Pancreas 38:282–288CrossRefPubMed

Takai S, Satoi S, Yanagimoto H et al (2008) Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer. Pancreas 36:e26–e32CrossRefPubMed

Wilkowski R, Wolf M, Heinemann V (2008) Primary advanced unresectable pancreatic cancer. Recent Results Cancer Res 177:79–93CrossRefPubMed

Wilkowski R, Thoma M, Bruns C et al (2006) Chemoradiotherapy with gemcitabine and continuous 5-Fu in patients with primary inoperable pancreatic cancer. JOP 7:349–360PubMed

Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer. JAMA 297:267–277CrossRefPubMed

Japan Pancreas Society (2009) General rules for the study of pancreatic cancer, 6th edn. Kanehara, Tokyo

Friess H, Langhans J, Ebert HG et al (1995) Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-d-glucose positron emission tomography. Gut 36:771–777CrossRefPubMed

Stollfuss JC, Glatting G, Friess H et al (1995) 2-(fluorine-18)-Fluoro-2-deoxy-d-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 195:339–344PubMed

Koyama K, Okamura T, Kawabe J et al (2001) Diagnostic usefulness of FDG PET for pancreatic mass lesions. Ann Nucl Med 15:217–224CrossRefPubMed

10.

Higashi T, Tamaki N, Honda T et al (1997) Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. J Nucl Med 38:1337–1344PubMed

11.

Lee JD, Yang WI, Park YN et al (2005) Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increase (18)F-FDG uptake. J Nucl Med 46:1753–1759PubMed

12.

Higashi T, Saga T, Nakamoto Y et al (2002) Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43:173–180PubMed

13.

Vansteenkiste JF, Stroobants SG, Dupont PJ et al (1999) Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: analysis of 125 cases. J Clin Oncol 17:3201–3206PubMed

14.

Downey RJ, Akhurst T, Gonen M et al (2004) Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22:3255–3260CrossRefPubMed

15.

Cerfolio RJ, Bryant AS, Ohja B et al (2005) The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 130:151–159CrossRefPubMed

16.

Rizk N, Downey RJ, Akhurst T et al (2006) Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg 81:1076–1081CrossRefPubMed

17.

Wakabayashi H, Nishiyama Y, Otani T et al (2008) Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol 14:64–69CrossRefPubMed

18.

van Kouwen MC, Jansen JB, van Goor H et al (2005) FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging 32:399–404CrossRefPubMed

19.

Seo S, Doi R, Machimoto T et al (2008) Contribution of 18F-fluorodexyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg 15:634–639CrossRefPubMed

20.

Delbeke D, Pinson CW (2004) Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. J Hepatobiliary Pancreat Surg 11:4–10CrossRefPubMed

21.

Parson CM, Sutcliffe JL, Bold RJ (2008) Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 15:429–435CrossRef

22.

Maemura K, Takao S, Shinchi H et al (2006) Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. J Hepatobiliary Pancreat Surg 13:435–441CrossRefPubMed

23.

Doi R, Imamura M, Hosotani R et al (2008) Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial. Surg Today 38:1021–1028CrossRefPubMed

24.

Imamura M, Doi R, Imaizumi T et al (2004) A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 136:1003–1011CrossRefPubMed

25.

Showalter TN, Rao AS, Rani Anne P et al (2009) Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis. Ann Surg Oncol 16:2116–2122CrossRefPubMed

26.

Ogawa K, Karasawa K, Ito Y et al (2010) Intraoperative radiotherapy for resected pancreatic cancer. Int J Radiat Oncol Biol Phys 3:734–742

27.

Choi M, Heilbrun LK, Venkatramanamoorthy R et al (2010) Using ¹⁸F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer. Am J Clin Oncol 33:257–261PubMed

28.

Wieder HA, Ott K, Lordick F et al (2007) Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction. Eur J Nucl Med Mol Imaging 34:1925–1932CrossRefPubMed

29.

Farrag A, Ceulemans G, Voordeckers M et al (2010) Can ¹⁸F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients? Nucl Med Commun 31:495–501PubMed

Titel: Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection
verfasst von: Kojun Okamoto
Isamu Koyama
Mitsuo Miyazawa
Yasuko Toshimitsu
Masayasu Aikawa
Katsuya Okada
Etsuko Imabayashi
Hiroshi Matsuda
Publikationsdatum: 01.02.2011
Verlag: Springer Japan
Erschienen in: International Journal of Clinical Oncology / Ausgabe 1/2011
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-010-0124-z

Springer Medizin

Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection